VX-A903-1

N/A

Report date: 2025/11/06 17:16:07

Base Information

Drug NameVX-A903-1

Drug Alias NameVX-A903-1

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVERAXA Biotech AG

China Registration ClassN/A

Develop Information

Active CompaniesVERAXA Biotech AG

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A